12/15/2025
Brilliant webinar on the latest PANS/PANDAS research, highlighting key research that could help bridge the gap between what is well established in neuroscience and what has yet to be fully translated into clinical care:
https://www.pandasppn.org/neuroimmune-epigenetic-webinar/
“Scientific understanding of immune–brain interactions has significantly advanced in the last decade, but translation into clinical care is lacking.”
—Dr. Russell Dale
🧬 Dr. Dale shared over a decade of work in epigenetic neuroimmunology, emphasizing immune–brain cross-talk, microglia as immune cells of the brain (~10% of brain cells), and gene–environment interactions. Many patients have normal MRI, CSF, and bloodwork, yet show meaningful clinical response to anti-inflammatories, antibiotics, and IVIG. Dale's research focused on this question: one disease or a clinical syndrome with complex, individualized biology? The findings point to the latter.
🧬 Research from Columbia and Stanford continues to clarify the role of blood–brain barrier disruption and neuroinflammation. Dr. Jennifer Frankovich highlighted emerging evidence linking autoimmunity with OCD, eating disorders, and arthritis, reinforcing shared immune-driven mechanisms across these presentations.
🧬Clinical takeaways:
-Evidence of strep (throat culture or titers in blood) are often missed due to timing, making PANS more clinically useful than strict PANDAS criteria
-Children with PANS are often highly sensitive to psychotropics Neuropsychiatric symptoms may respond to very low-dose D2 blockade (e.g., risperidone), clonidine or guanfacine, and SSRIs for OCD—started low and escalated slowly
-Recovery requires rehabilitating the brain, not just symptom suppression: CBT, ERP, SPACE, parent management, plus PT, OT, and speech therapy when indicated
As both a mother and clinician who has witnessed PANS firsthand, I am committed to ensuring this condition is acknowledged and appropriately addressed in clinical care. We all share a responsibility to keep our understanding of the neuroimmune system aligned with the latest research, and I am passionate about championing this in both the clinic and the community.
This webinar explores the latest research on PANS and PANDAS. The session examines the roles of neuroimmune and epigenetic factors in children, and discusses whether these conditions are best